Effect of Transcranial Alternative Current Stimulation at Alpha Frequency (α-tACS) on Stressed Healthy Subjects

Launched by HÔPITAL LE VINATIER · Jan 25, 2024

Keywords

ClinConnect Summary

This clinical trial is studying the effects of a treatment called Transcranial Alternating Current Stimulation (tACS) on healthy individuals who are experiencing stress. The goal is to see if applying a mild electrical current to the scalp at a specific frequency (known as alpha frequency) can help manage the body's stress response. Researchers believe that this treatment may influence how our brain responds to stress, potentially improving how we handle it.

To participate in the trial, individuals must be right-handed men and women aged 18 to 45 who can read and speak French. Women will need to use hormonal contraception. Participants cannot have any current psychiatric disorders or be taking certain medications. Those who join the study can expect to receive tACS treatment and will help researchers understand how it affects stress levels and related brain functions. It’s important to note that this trial is currently looking for volunteers, and participants will need to provide written consent before taking part.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Right-handed Men and Women aged between 18 and 45
• • If woman, hormonal contraception required
• • Having given their written informed consent
• • Affiliated with a social security scheme
• • French speakers and readers
• Exclusion Criteria:
• • Contraindication to the exposure to exposure to tACS
• • Current psychiatric disorder as classified in the DSM-5
• • Regular intake of any psychotropic drug or Beta Blocker
• • Recent exposure to a traumatic event
• • Any debilitating condition making the experimental procedure not feasible
• • Pregnancy